SPP1 and peripheral arterial disease: Recently, a cross-sectional study enrolling 70 individuals with T2DM and 66 controls, showed significantly higher plasma OPN levels in PAD patients compared to PAD-free counterparts (p < 0.001), regardless of their glycaemic status [23].